“REDISCOVERING ARNETH COUNT” PREVALENCE OF MEGALOBLASTIC ANEMIA IN CHRONIC MET-FORMIN USERS AT GOVERNMENT STANLEY HOSPITAL,CHENNAI
Abstract
Full Text:
PDFReferences
Reinstatler L, Qi YP, Williamson RS, Garn JV,Oakley GP Jr. Association of biochemical B12deficiency with metformin therapy and vita-min B12 supplements: the National Health and Nutrition Examination Survey,1999-2006. Diabe-tes Care 2012;35:327–333
De Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12deficiency: ran-domised placebo controlled trial., BMJ 2010;340:c2181
Ting RZ, Szeto CC, Chan MH, et al. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med 2006;166:1975–1979.
Swain R: Stages of B12 deficiency. In Round Table Series 66: Vitamin B12 Deficiency. Herbert V, Ed. London, The Royal Society ofMedicine Press, 1999, p. 19–20 DIABETES
Hermann LS, Nilsson B, Wettre S. Vitamin B12 status of patients treated with metformin: a crosssectional cohort study. Br J Diabetes Vasc Dis 2004; 4:401– 6.
Filioussi K, Bonovas S, Katsaros T. Should we screen diabetic patients using biguanides for megaloblastic anaemia? Aust Fam Physician 2003;32: 383– 4.
Tomkin GH, Hadden DR, Weaver JA, Montgom-ery DA. Vitamin- B12 status of patients on long-term metformin therapy. Br Med J 1971;2:685–7.
Bell DS. Nondiabetic neuropathy in a patient with diabetes. Endocr Pract 1995;1:393– 4.
Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in patho-physiology, diagnosis and treatment. Blood Rev 2007;21:113–130
CHANARIN I: Investigation and management of megaloblastic anemia. Clin Haematol
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University